Fast-track in Minimally Invasive Gynaecology

April 9, 2021 updated by: Shahzia Lambat, University Hospital, Geneva

Fast-track in Minimally Invasive Gynaecology: a Randomized Trial Comparing Costs and Clinical Outcomes

Objective: Evaluate the effects of a fast-track (FT) protocol on costs and postoperative recovery.

Design: randomized trial

Setting: University Hospitals

Population: 170 women undergoing total laparoscopic hysterectomy for a benign indication

Methods: A FT protocol included the combination of minimally invasive surgery, analgesia optimization, early oral refeeding and rapid mobilization of patients was compared to a usual care protocol.

Main outcomes measure: Primary outcome was costs. Secondary outcomes were length of stay, postoperative morbidity and patient satisfaction.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

  1. Fast-Track protocol:

    Preoperative

    • Anesthetic consultation
    • Proposal of optimization of patient's general health state + family meeting if necessary
    • Hospitalization on day of surgery
    • Solids stopped 6 hours prior to surgery, drinking encouraged up to 2 hours prior to surgery

    During surgery

    • Anti-infectious prophylaxis
    • Anesthesia via IV propofol/remifentanil
    • Anti-nausea prophylaxis
    • Pain control based on limited systemic opioid use

    Postoperative

    • Balanced analgesia for pain control
    • Antithrombotic prophylaxis
    • Early oral refeeding
    • Rapid mobilization
    • Gum chewing
    • Foley catheter removal at the end of surgery
    • Peripheral IV catheter removal 6 hours postoperatively
  2. Usual care protocol :

Preoperative

  • Anesthetic consultation
  • Hospitalization on day of surgery
  • Fasting beginning at midnight prior to surgery

During surgery

  • Anti-infectious prophylaxis
  • Balanced anesthesia via halogen gas
  • Anti-nausea medication if needed

Postoperative

  • Balanced analgesia for pain control
  • Antithrombotic prophylaxis
  • Same-day refeeding according to patient's wish
  • Same-day mobilization according to patient's wish
  • Foley and peripheral IV catheter removal on day 1 postoperatively

Study Type

Interventional

Enrollment (Actual)

170

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Geneva, Switzerland
        • HUG
      • Geneva, Switzerland
        • University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • women undergoing total laparoscopic hysterectomy for a benign indication

Exclusion Criteria:

  • the requirement for an additional surgical procedure, such as prolapse repair or urinary incontinence, because a prolonged operative time could compromise early patient discharge and
  • the inability to speak French because the patients were required to complete their data collection logbook in French.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: "FAST TRACK" protocol

"FAST TRACK" protocol Preoperative evaluation and information

Patient general health state optimization proposal prior to hospitalization:

Preoperative strategy:

  • Hospitalization on surgery day
  • No prolonged fasting

Perioperative strategy:

  • Pain control based on limited systemic opioid therapy use
  • Anti-nausea prophylaxis
  • Anaesthesia via IV propofol / remifentanyl
  • Bladder catheter removal postoperative

Postoperative strategy:

  • Pain control using balanced analgesia
  • Gum chewing
  • Early oral refeeding and rapid mobilization
  • Venflon removal 6 hours post-op

Preoperative evaluation and information

Patient general health state optimization proposal prior to hospitalization:

Preoperative strategy:

  • Hospitalization on surgery day
  • No prolonged fasting

Perioperative strategy:

  • Pain control based on limited systemic opioid therapy use
  • Anti-nausea prophylaxis
  • Anaesthesia via IV propofol / remifentanyl
  • Bladder catheter removal postoperative

Postoperative strategy:

  • Pain control using balanced analgesia
  • Gum chewing
  • Early oral refeeding and rapid mobilization
  • Venflon removal 6 hours post-op
No Intervention: "Conventional setting" protocol

"Conventional setting" protocol

Preoperative strategy:

  • Hospitalization on surgery day
  • Fasting as of midnight prior to the day of surgery

Perioperative strategy:

- Balanced anaesthesia via halogens gases

Postoperative strategy:

  • Same day refeeding and mobilization minimum 6 hours post operation
  • Bladder catheter and Venflon removal on day 1

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital costs and ambulatory costs
Time Frame: Up to 1 month postoperative
The economic evaluation covered hospital inpatient surgical care costs and ambulatory costs. Resource inputs were divided into two main categories: (1) hospital inpatient surgical costs and (2) ambulatory costs further divided into (2a) hospital-related costs (A&E Department consultations and hospital readmission) and (2b) community costs (community health + social costs and caregiver's loss of production costs). Hospital costs were collected using a computerized hospital information system developed by the University Hospitals of Geneva. The patients recorded community costs in a logbook containing the community health and social invoices and caregivers' number of absent working days. Caregivers' loss of production was extrapolated via Switzerland's median wage per working day.
Up to 1 month postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital length of stay
Time Frame: Up to 1 month postoperative
Hospital stay was retrieved from the computerized patient record
Up to 1 month postoperative
Postoperative morbidity rate during the first postoperative month
Time Frame: Up to 1 month postoperative
Morbidity during the first postoperative month was monitored via patient consultations at the Accident and Emergency (A&E) Department
Up to 1 month postoperative
Satisfaction assessed by a three-point likert scale
Time Frame: Up to 1 month postoperative
Patient satisfaction was evaluated on their day of discharge and at their 1-month postoperative follow-up visit based on a three-point likert scale regarding their satisfaction with the care they received. The likert scale ranged from 0 (unsatisfied) to 2 (satisfied).
Up to 1 month postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shahzia Lambat, HUG

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2015

Primary Completion (Actual)

March 1, 2021

Study Completion (Actual)

March 1, 2021

Study Registration Dates

First Submitted

March 31, 2021

First Submitted That Met QC Criteria

April 8, 2021

First Posted (Actual)

April 9, 2021

Study Record Updates

Last Update Posted (Actual)

April 14, 2021

Last Update Submitted That Met QC Criteria

April 9, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • CCER 15-103

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gynecologic Disease

Clinical Trials on "FAST TRACK" protocol

3
Subscribe